| Serial Number | 90612657 |
| Word Mark | ADITXT IMMUNE HEALTH |
| Filing Date | Tuesday, March 30, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 23, 2021 |
| Description of Mark | The mark consists of an array of seven shaded-in circles arranged in a general square outline with three shaded-in tear drop elements with a shaded-in circle at each end appearing within the square and wherein the tear drop elements are connected together to form linked structures, to the right is the word, "ADITXT", appearing above the smaller wording, "IMMUNE HEALTH". |
| Goods and Services | Pharmaceutical preparations and therapeutic agents for reprogramming the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance |
| Pseudo Mark | ADITX THERAPEUTICS IMMUNE HEALTH |
| Goods and Services | Health care services, namely, medical analysis services for diagnostic, treatment and information purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic, treatment and information purposes; advisory services relating to health; providing information in the field of health |
| NOT AVAILABLE | "IMMUNE HEALTH" |
| Goods and Services | Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research; medical laboratory services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 8, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 8, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADITXT, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Richmond, VA 23219 |
| Party Name | ADITXT, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | MOUNTAIN VIEW, CA 94043 |
| Party Name | Aditx Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Mountain View, CA 94043 |
| Event Date | Event Description |
| Friday, September 24, 2021 | ASSIGNED TO EXAMINER |
| Friday, April 2, 2021 | NEW APPLICATION ENTERED |
| Thursday, July 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 9, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, September 22, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, September 27, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 27, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 27, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, September 27, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 20, 2021 | PRIORITY ACTION WRITTEN |
| Wednesday, October 20, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, September 27, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 12, 2021 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, October 20, 2021 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, October 20, 2021 | PRIORITY ACTION E-MAILED |
| Wednesday, October 20, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, October 20, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, October 20, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 20, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 20, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 3, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 23, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 23, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 18, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, March 23, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, March 23, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, March 23, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 18, 2022 | SOU EXTENSION 1 FILED |
| Monday, July 18, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 18, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, July 20, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 17, 2023 | SOU EXTENSION 2 FILED |
| Tuesday, January 17, 2023 | SOU EXTENSION 2 GRANTED |
| Wednesday, July 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 19, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 17, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 17, 2023 | SOU EXTENSION 3 FILED |
| Monday, July 17, 2023 | SOU EXTENSION 3 GRANTED |
| Thursday, January 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 18, 2024 | SOU EXTENSION 4 FILED |
| Thursday, January 18, 2024 | SOU EXTENSION 4 GRANTED |
| Saturday, January 20, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 19, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, August 19, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |